
    
      This is a phase 4, prospective, sequential, open-label study designed to evaluate the
      efficacy, safety, and health economic benefits of intraoperative local wound infiltration
      with EXPAREL (bupivacaine liposome extended-release injectable suspension) compared with
      postsurgical administration of standardized intravenous (IV) morphine sulfate for
      postsurgical analgesia in adult patients undergoing open colectomy with general anesthesia.
    
  